Shandong Lukang Pharmaceutical announced that the company plans to renew the "Trademark License Agreement" with its controlling shareholder Hualu Group. According to the agreement, the company will continue to use the registered trademark "Lukang" and related product trademarks, with an annual license fee of 7.6 million yuan, and the agreement is valid for the entire year of 2025.
鲁抗医药：拟与华鲁集团续签《商标使用许可协议》
Shandong Lukang Pharmaceutical: Plans to renew the "Trademark License Agreement" with Hualu Group.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Investment Course
Choose stocks based on financial reports
Quickly master financial season learning guidelines
When the financial season comes, company stock prices are the most likely to rise and fall, and many excellent investors will see the financial season as a good
[2025.2] How should NVIDIA's performance be viewed? The key indicator to watch for short-term stock prices is this.
NVIDIA has been one of the best-performing Technology giants in the US stock market over the past two years, and since 2024, its stock price has experienced sig
How to view Tesla's performance in January 2025? Pay attention to these four key points.
It's earnings season for US stocks again. The performance of giant companies not only affects their own stock prices but also influences the overall trend of th